SCHEMBL21716780

SCHEMBL21716780

c1ccc(-c2nc3ccccc3nc2-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3cc4ccccc4cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
HSD17B10 Q99714 2/20 0.38
CASP1 P29466 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
KDM4E B2RXH2 6/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
ATM Q13315 1/20 0.36
NPY5R Q15761 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE10A Q9Y233 2/20 0.34
TERT O14746 1/20 0.34
HTT P42858 1/20 0.34
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716924 1.00 ESR1 (0.39) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21716784 0.98 ESR1 (0.37) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21716925 0.98 ESR1 (0.37) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL22425456 0.95 ESR1 (0.39) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21717066 0.94 ESR1 (0.36) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21716200 0.94 ESR1 (0.36) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL18415423 0.94 HSD17B10 (0.42) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL19507463 0.93 ESR1 (0.44) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21168868 0.92 HPGD (0.37) ESR1ESR2HSD17B10CASP1HRH4
SCHEMBL21168883 0.92 HPGD (0.37) ESR1ESR2HSD17B10CASP1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
WO-2020185059-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2020-09-17 WO disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ESR1 195/4885ESR2 1326/4885HSD17B10 1118/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ESR1 195/4885ESR2 1326/4885HSD17B10 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.